For the new Mu mutation; of Covid-19, cases of which were also detected in our country, spoke pAthens 9.84 and Eleftheria Koumantou and Eleonora Orfanidou, the Pathologist-Infectious Diseases Specialist, Professor of Pathology at the University of Patras and member of the Committee of Experts, Mr. Charalambos Gogos.
As he explained, there are not yet enough clinical data so it is too early to draw conclusions about the possibility of its prevalence over the Delta mutation, however, great care and study is required to see how it develops.
The one that prevails at the given time and constitutes 90% and more of the executives not only in our country but also worldwide, is the well-known "Delta" mutation. We are chasing her and fortunately, the possibilities we have with the vaccines to cover her are extremely satisfactory. But when a new executive appears, we need to be very careful in order to see if he will prevail ".
He noted that although the spread of the Mu mutation may be less than 1% both globally and in our country, however, The fact that it has prevailed in some countries is particularly worrying.
"We do not yet know the clinical behavior of the Mu mutation; He is an executive under surveillance. Our main problems are whether it will prevail or whether it will be covered by the "Delta" mutation and will be lost. Therefore, continuous monitoring of the virus strains is required to have better data at the clinical level regarding the transmissibility that seems to be similar to "Delta" but also about the possibility of escaping the immunity resulting from disease or vaccination ".
Mr. Gogos clarified that in order for mutations to exist, the virus must exist, emphasizing the decisive contribution of vaccination in the fight against the pandemic.
«The chances of mutations increase as the viral load in the community increases. Because viral load is currently mainly associated with reduced vaccination coverage, the less vaccinated people are, the more the virus circulates and multiplies. Our goal is to reduce the circulation of the virus as well as the serious cases that exist in hospitals. "Vaccination, to a large extent, helps to reduce the viral load in the community as well as the mutations."